News tagged drug-utilization-review
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →Oregon News: Adult Prescription Dispensed to Four Year Old
Published in the February 2009 Oregon State Board of Pharmacy Newsletter A recent complaint that resulted in a case being presented to the Board illustrates a common break down in the most basic principles of pharmacy practice. Case No. 08-0400...
Read More →New Mexico News: Regulation Changes
Published in the September 2008 New Mexico Board of Pharmacy Newsletter The Pharmacy Regulation, Part 6, was revised during the June 16-17, 2008 New Mexico Board of Pharmacy meeting. The amendment allows drug utilization reviews (DUR) to be done at...
Read More →Vermont News: Are You Performing Prospective DUR As Required?
Published in the September 2007 Vermont Board of Pharmacy Newsletter Prospective Drug Utilization Review (DUR) is required to be done by each pharmacist before they dispense a prescription (see Pharmacy Rule 19.9). The purpose of DUR is to improve the...
Read More →Minnesota News: Certification and Quality Assurance
Reprinted from the July 2007 Minnesota Board of Pharmacy Newsletter. Pharmacists are reminded that there is a difference between certification and quality assurance, and that both are required per Minnesota Rules. Certification is the process by which one pharmacist or...
Read More →